Medication access means how patients get their prescribed drugs quickly and affordably. This process involves many administrative steps such as prior authorizations, insurance eligibility checks, appeals, and following federal rules like the 340B Drug Pricing program. These steps are important to make sure patients get the right medicine but they often take a long time.<\/p>\n
<\/p>\n
Recent data shows that hospitals and pharmacies often face delays because prior authorization reviews take a long time. These delays can stop patients from getting care on time. The extra paperwork also causes stress for doctors, nurses, and pharmacists because they spend more time on forms than with patients.<\/p>\n
<\/p>\n
For example, Ochsner Health runs 46 hospitals and over 370 urgent care and health centers in multiple states. They care for more than 1.6 million patients every year. With so many medication requests and insurance steps, using technology to manage medication access is necessary.<\/p>\n
<\/p>\n
One important development to improve medication access is using AI for real-time eligibility audits. These systems check patients\u2019 insurance and benefits right away. This lets pharmacies and healthcare staff know what medicines are covered without waiting a long time.<\/p>\n
<\/p>\n
AI uses machine learning and big sets of data from insurance companies and pharmacy benefit managers to check coverage accurately. This reduces mistakes and uncertainty about medication approval. For instance, Latent Health\u2019s AI system, used by Ochsner Health, cut prior authorization review times to four or five minutes. This speed is about 75% faster than usual. Faster reviews help patients start their medicine sooner, which is very important for special pharmacy or infusion therapy where timing affects health.<\/p>\n
<\/p>\n
Compliance management is also a big concern in medication access. Programs like 340B give discounts on medicine to certain healthcare groups that serve needy populations. These programs need strict following of federal rules. AI helps by automating compliance checks, making sure pharmacies meet all rules and avoid fines while keeping correct medication distribution.<\/p>\n
<\/p>\n
AI can also help when prior authorizations are denied. Instead of slow manual reviews, AI looks at clinical papers and insurance rules quickly to create appeals. This raises the chances of getting approvals and cuts down on therapy delays.<\/p>\n
<\/p>\n
The partnership between Ochsner Health and Latent Health shows how AI can help large U.S. healthcare systems with medication access. In November 2023, Latent\u2019s AI platform started as a pilot project within Ochsner\u2019s pharmacies. It worked to automate and improve prior authorizations for specialty, infusion, and retail pharmacies.<\/p>\n
<\/p>\n
After 18 months, the AI system expanded to cover the whole organization. The system now helps with prior authorizations, eligibility checks, appeals, and compliance audits for over 40,000 employees and nearly 5,000 doctors. A new three-year contract was finalized in mid-2025.<\/p>\n
<\/p>\n
Deborah Simonson, Vice President and Chief Pharmacy Officer at Ochsner Health, said the AI system \u201cremoves the administrative burden that keeps nurses and pharmacists in front of screens instead of patients.\u201d This shows that AI helps medical staff spend more time caring for patients and less time on paperwork.<\/p>\n
<\/p>\n
Amy Trainor, RN and Ochsner\u2019s Chief Information Officer, called Latent a \u201ctrusted partner\u201d whose technology fits Ochsner\u2019s long-term goal of combining innovation with good patient care. This team effort between AI technology and healthcare groups shows how thoughtful use of AI can improve results without lowering standards.<\/p>\n
<\/p>\n
These improvements not only speed up medication access but also help pharmacy teams feel less frustrated with paperwork.<\/p>\n
<\/p>\n
Besides eligibility checks and compliance audits, AI also changes how workflows are managed in healthcare. AI helps automate routine administrative tasks by handling complex data and decisions.<\/p>\n
<\/p>\n
AI platforms can automate many steps in medication approval, such as:<\/p>\n
Automated data collection: Gathering patient medical records, insurance info, and payer rules into one system.<\/p>\n<\/li>\n
Predictive analytics: Using past data to predict approval chances and prepare pre-authorization paperwork.<\/p>\n<\/li>\n
Real-time status monitoring: Tracking prior authorization requests and alerting staff about delays or extra information needed.<\/p>\n<\/li>\n
Appeals management: Automatically creating evidence-based appeal letters when approvals are denied.<\/p>\n<\/li>\n
Inventory and supply chain coordination: Predictive models help manage medicine stock based on patient needs and approval rates.<\/p>\n<\/li>\n<\/ul>\n
<\/p>\n
For medical practice leaders and IT managers in the U.S., these AI tools mean fewer errors, clearer workflows, and faster processing times. This leads to better control and use of resources.<\/p>\n
<\/p>\n
AI workflow tools are also built to grow and adapt. When new rules or insurer policies change, AI systems can update quickly to keep working smoothly and following guidelines.<\/p>\n
<\/p>\n
Healthcare IT leaders who use AI platforms like Latent\u2019s see they can handle medication access challenges better. This frees medical staff from repetitive tasks and lets them focus more on patient care.<\/p>\n
<\/p>\n
AI not only helps with medication access and pharmacy workflows but also affects the pharmaceutical industry and healthcare supply chains more widely. AI is used in places like drug discovery, making drugs, quality checks, and monitoring drugs after market release.<\/p>\n
<\/p>\n
For example, AI uses machine learning and predictive models to speed up drug discovery and make better drug formulas. This helps medication availability and safety. AI also supports real-time monitoring of production lines to increase efficiency and keep product quality steady.<\/p>\n
<\/p>\n
On the supply side, AI improves inventory management by predicting demand. This helps healthcare systems keep enough medicine in stock without too much or too little. This is important for big networks like Ochsner Health because poor stock management could delay treatment for many patients.<\/p>\n
<\/p>\n
In drug safety monitoring, AI reviews huge amounts of data to find harmful drug effects early, supporting safety and government compliance.<\/p>\n
<\/p>\n
For healthcare providers in the U.S., using AI to improve medication access helps fix several ongoing challenges:<\/p>\n
Fragmented insurance landscape: The varied and complex insurance rules in the U.S. require constant checks of coverage and benefits, which AI can do faster than people.<\/p>\n<\/li>\n
Regulatory compliance: Following government programs like 340B needs continuous audits and precise records. AI automates this to lower human mistakes.<\/p>\n<\/li>\n
High patient volume: Large healthcare systems serve millions yearly, increasing the need for technology that can handle scale.<\/p>\n<\/li>\n
Provider burnout: AI cuts down repetitive clerical work, reducing staff stress and helping keep workers longer.<\/p>\n<\/li>\n
Timely patient care: Faster prior authorizations and eligibility checks lead to better patient results by reducing treatment delays.<\/p>\n<\/li>\n<\/ul>\n
<\/p>\n
Medical practice owners and managers can think of AI as a smart choice to run operations better, meet rules, and improve patient satisfaction.<\/p>\n
<\/p>\n
Artificial intelligence is changing how medication access is handled in U.S. healthcare. Real-time eligibility audits, compliance management, and automated workflows using AI platforms like Latent Health\u2019s bring clear improvements to pharmacy work.<\/p>\n
<\/p>\n
These changes reduce paperwork for nurses and pharmacists, speed up the time patients get their medicine, and make medication delivery safer and more reliable.<\/p>\n
<\/p>\n
Ochsner Health\u2019s example shows practical benefits that other large healthcare providers can reach too. As AI use grows, healthcare groups with such systems will be better prepared to handle new challenges and provide efficient care focused on patients.<\/p>\n
<\/p>\n
For medical practice leaders, owners, and IT staff, learning how AI works and what it can do for medication access is key for smart planning and making good use of resources. Investing in AI tools can help create smoother pharmacy operations and better care for patients in a complicated healthcare system.<\/p>\n The partnership aims to accelerate AI-driven medication access by optimizing pharmacy workflows and boosting clinical productivity, specifically focusing on specialty, infusion, and retail pharmacy prior authorizations.<\/p>\n<\/p><\/div>\n<\/details>\n The collaboration began in November 2023, initially as a design partnership to develop clinical AI tools for prior authorizations.<\/p>\n<\/p><\/div>\n<\/details>\n Latent has reduced prior authorization review times to four to five minutes, which is 75% faster than industry benchmarks, thus accelerating time-to-therapy and improving pharmacy team morale.<\/p>\n<\/p><\/div>\n<\/details>\n The platform powers prior authorization workflows for pharmacy and medical benefits, manages appeals, and performs real-time eligibility audits across Ochsner’s expanding pharmacy network while enabling new product development.<\/p>\n<\/p><\/div>\n<\/details>\n It removes the administrative burden of screen time, allowing nurses and pharmacists to spend more time with patients and reduces workflow inefficiencies.<\/p>\n<\/p><\/div>\n<\/details>\n The collaboration supports delivering exceptional care, driving innovation, and creating streamlined workflows to enhance patient outcomes and operational efficiency.<\/p>\n<\/p><\/div>\n<\/details>\n Latent also supports 340B compliance, appeals processing, and helps scale pharmacy expansion by optimizing and centralizing workflows.<\/p>\n<\/p><\/div>\n<\/details>\n Ochsner Health operates 46 hospitals and 370+ health and urgent care centers, caring for over 1.6 million people annually, with more than 40,000 employees and 4,900 physicians.<\/p>\n<\/p><\/div>\n<\/details>\n Ochsner was ranked No. 1 hospital in Louisiana for 13 consecutive years and its children\u2019s hospital received top pediatric rankings for four years by U.S. News & World Report.<\/p>\n<\/p><\/div>\n<\/details>\n The partnership facilitates continuous iteration and development of new AI products for medication access use cases, setting new operational standards and enabling scalability throughout the health system.<\/p>\n<\/p><\/div>\n<\/details><\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":" Medication access means how patients get their prescribed drugs quickly and affordably. This process involves many administrative steps such as prior authorizations, insurance eligibility checks, appeals, and following federal rules like the 340B Drug Pricing program. These steps are important to make sure patients get the right medicine but they often take a long time. […]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-139994","post","type-post","status-publish","format-standard","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/posts\/139994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/comments?post=139994"}],"version-history":[{"count":0,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/posts\/139994\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/media?parent=139994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/categories?post=139994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/tags?post=139994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Frequently Asked Questions<\/h2>\n
What is the purpose of the partnership between Ochsner Health and Latent?<\/summary>\n
When was the collaboration between Ochsner Health and Latent initiated?<\/summary>\n
What measurable impact has Latent’s AI platform achieved at Ochsner Health?<\/summary>\n
How is Latent’s platform being used enterprise-wide at Ochsner Health?<\/summary>\n
What benefits does AI-driven prior authorization bring to nursing and pharmacy staff?<\/summary>\n
How does the partnership align with Ochsner Health’s long-term vision?<\/summary>\n
What role does Latent play in medication access beyond prior authorizations?<\/summary>\n
What scale and reach does Ochsner Health have as a healthcare provider?<\/summary>\n
What recognition has Ochsner Health received that underscores its leadership?<\/summary>\n
How does Latent\u2019s AI platform contribute to future innovation at Ochsner Health?<\/summary>\n